[MRDIY] QoQ Quarter Result on 30-Sep-2021 [#3]

Stock
[MRDIY] MR D.I.Y. GROUP (M) BERHAD
Announcement Date
02-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
30-Sep-2021 [#3]
Profit Trend
QoQ- 10.0%
YoY- -20.36%
Quarter Report
Latest QR
Upcoming QR
MRDIY's Result
MRDIY's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 1,048,734 905,163 975,388 768,021 759,818 870,181 768,332 23.11%
PBT 183,293 134,522 179,146 124,029 112,551 170,682 142,486 18.33%
Tax -48,106 -34,021 -44,594 -33,678 -30,417 -45,891 -34,220 25.56%
NP 135,187 100,501 134,552 90,351 82,134 124,791 108,266 16.00%
-
NP to SH 135,187 100,501 134,552 90,351 82,134 124,791 108,266 16.00%
-
Tax Rate 26.25% 25.29% 24.89% 27.15% 27.03% 26.89% 24.02% -
Total Cost 913,547 804,662 840,836 677,670 677,684 745,390 660,066 24.26%
-
Net Worth 1,292,258 1,254,479 1,148,922 1,047,564 992,958 1,003,000 876,840 29.59%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 56,553 43,972 56,504 40,797 37,659 50,212 45,819 15.10%
Div Payout % 41.83% 43.75% 41.99% 45.15% 45.85% 40.24% 42.32% -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 1,292,258 1,254,479 1,148,922 1,047,564 992,958 1,003,000 876,840 29.59%
NOSH 9,426,499 6,283,180 6,280,251 6,276,600 6,276,600 6,276,600 6,276,600 31.24%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 12.89% 11.10% 13.79% 11.76% 10.81% 14.34% 14.09% -
ROE 10.46% 8.01% 11.71% 8.62% 8.27% 12.44% 12.35% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 11.13 14.41 15.54 12.24 12.11 13.86 12.24 -6.15%
EPS 1.43 1.60 2.14 1.44 1.31 1.99 1.72 -11.61%
DPS 0.60 0.70 0.90 0.65 0.60 0.80 0.73 -12.28%
NAPS 0.1371 0.1997 0.183 0.1669 0.1582 0.1598 0.1397 -1.24%
Adjusted Per Share Value based on latest NOSH - 6,276,600
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 11.09 9.58 10.32 8.13 8.04 9.21 8.13 23.06%
EPS 1.43 1.06 1.42 0.96 0.87 1.32 1.15 15.68%
DPS 0.60 0.47 0.60 0.43 0.40 0.53 0.48 16.08%
NAPS 0.1367 0.1327 0.1215 0.1108 0.105 0.1061 0.0928 29.55%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 2.07 3.46 3.61 3.90 3.59 4.12 3.12 -
P/RPS 18.60 24.01 23.24 31.87 29.66 29.72 25.49 -18.99%
P/EPS 144.33 216.27 168.44 270.93 274.34 207.22 180.88 -14.00%
EY 0.69 0.46 0.59 0.37 0.36 0.48 0.55 16.36%
DY 0.29 0.20 0.25 0.17 0.17 0.19 0.23 16.76%
P/NAPS 15.10 17.33 19.73 23.37 22.69 25.78 22.33 -23.01%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 04/08/22 13/05/22 16/02/22 02/11/21 05/08/21 30/04/21 17/02/21 -
Price 2.32 3.55 3.79 3.56 3.38 3.99 3.41 -
P/RPS 20.85 24.64 24.40 29.09 27.92 28.78 27.86 -17.61%
P/EPS 161.76 221.89 176.84 247.31 258.30 200.68 197.69 -12.54%
EY 0.62 0.45 0.57 0.40 0.39 0.50 0.51 13.94%
DY 0.26 0.20 0.24 0.18 0.18 0.20 0.21 15.34%
P/NAPS 16.92 17.78 20.71 21.33 21.37 24.97 24.41 -21.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment